Published in Int J Obes (Lond) on April 01, 2006
Obese children and adolescents have elevated nighttime blood pressure independent of insulin resistance and arterial stiffness. Am J Hypertens (2014) 1.97
Microalbuminuria: causes and implications. Pediatr Nephrol (2011) 1.05
Cardiometabolic risk variables in overweight and obese children: a worldwide comparison. Cardiovasc Diabetol (2011) 1.05
Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics (2008) 1.04
Association between physical activity and metabolic syndrome: a cross sectional survey in adolescents in Ho Chi Minh City, Vietnam. BMC Public Health (2010) 1.02
Prevalence of the metabolic syndrome among obese adolescents enrolled in a multidisciplinary weight management program: clinical correlates and response to treatment. Metab Syndr Relat Disord (2009) 0.99
Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients. Clin J Am Soc Nephrol (2008) 0.96
The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children. Saudi J Gastroenterol (2012) 0.95
Diagnostic criteria patterns of U.S. children with Metabolic Syndrome: NHANES 1999-2002. Nutr J (2007) 0.95
Metabolic syndrome in a sample of the 6- to 16-year-old overweight or obese pediatric population: a comparison of two definitions. Ther Clin Risk Manag (2012) 0.82
Severity of non-alcoholic fatty liver disease is associated with high systemic levels of tumor necrosis factor alpha and low serum interleukin 10 in morbidly obese patients. Clin Exp Med (2015) 0.80
Anthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease. Paediatr Child Health (2008) 0.80
Association between Physical Activity and Metabolic Risk Factors in Adolescents: Tehran Lipid and Glucose Study. Int J Prev Med (2013) 0.80
Limited value of routine microalbuminuria assessment in multi-ethnic obese children. Pediatr Nephrol (2013) 0.77
Elevated Urinary T Helper 1 Chemokine Levels in Newly Diagnosed Hypertensive Obese Children. J Clin Res Pediatr Endocrinol (2015) 0.75
Is Neck Circumference an Indicator for Metabolic Complication of Childhood Obesity? Open Access Maced J Med Sci (2015) 0.75
Modernization and cardiometabolic risk in Samoan adolescents. Am J Hum Biol (2012) 0.75
Incremental Predictive Value of Serum AST-to-ALT Ratio for Incident Metabolic Syndrome: The ARIRANG Study. PLoS One (2016) 0.75
A Family History of Diabetes Modifies the Association between Elevated Urine Albumin Concentration and Hyperglycemia in Nondiabetic Mexican Adolescents. J Diabetes Res (2015) 0.75
Paediatrics, insulin resistance and the kidney. Pediatr Nephrol (2014) 0.75
Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet (1982) 6.93
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes. N Engl J Med (1979) 2.87
Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care (1980) 1.92
Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med (1984) 1.90
Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ (1993) 1.58
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia (1991) 1.55
Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet (1989) 1.55
Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens (2007) 1.55
Increased glomerular permeability to albumin induced by exercise in diabetic subjects. Diabetologia (1978) 1.51
Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia (1994) 1.50
Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int (1992) 1.47
Abnormalities of endocrine function in patients with clinically "silent" adrenal masses. Eur J Endocrinol (1995) 1.46
Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46
Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care (1997) 1.45
Erectile dysfunction after kidney transplantation: our 22 years of experience. Transplant Proc (2004) 1.40
Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level. Br J Haematol (1997) 1.40
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis (2012) 1.40
A man with diabetes and unexplained renal failure. Lancet (1998) 1.39
Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord (1999) 1.39
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma. Ann Oncol (2008) 1.34
Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J (Clin Res Ed) (1983) 1.31
Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr (2006) 1.31
Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord (2000) 1.31
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
Secretory granules of endocrine and chief cells of human stomach mucosa contain leptin. Int J Obes Relat Metab Disord (2000) 1.26
Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med (1983) 1.25
Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet (1980) 1.24
Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res (2001) 1.22
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia (1995) 1.22
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. J Clin Oncol (2000) 1.21
Genesis and evolution of diabetic nephropathy. J Clin Pathol (1981) 1.21
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia (1996) 1.21
The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabet Med (1987) 1.19
Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Lond) (1993) 1.16
Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. Atherosclerosis (2008) 1.14
Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol (2001) 1.13
Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ (1989) 1.13
Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest (1982) 1.13
Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes (2000) 1.07
Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int (1982) 1.07
Proteinuria in diabetes. Diabetologia (1983) 1.07
Gender variations of body composition, muscle strength and power output in morbid obesity. Int J Obes (Lond) (2005) 1.05
Leptin in the human stomach. Gut (2001) 1.05
Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1988) 1.04
Microalbuminuria as prediction of nephropathy in diabetics. Lancet (1982) 1.02
Postural instability of extremely obese individuals improves after a body weight reduction program entailing specific balance training. J Endocrinol Invest (2005) 1.01
Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia (1995) 1.00
Adiposity in children and adolescents: correlates and clinical consequences of fat stored in specific body depots. Pediatr Obes (2012) 0.98
Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord (2000) 0.98
Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial. Diabetes Care (2000) 0.97
Plantar flexor activation capacity and H reflex in older adults: adaptations to strength training. J Appl Physiol (1985) (2002) 0.97
Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes (2000) 0.95
Changes of autonomic cardiac profile after a 3-week integrated body weight reduction program in severely obese patients. J Endocrinol Invest (2003) 0.95
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia (2009) 0.95
Dietary composition and renal function in healthy subjects. Nephron (1987) 0.94
Beta 2-microglobulinaemia: a sensitive index of diminishing renal function in diabetics. Br Med J (Clin Res Ed) (1981) 0.93
Familial, hemodynamic and metabolic factors in the predisposition to diabetic kidney disease. Kidney Int (1994) 0.92
Random motor unit activation by electrostimulation. Int J Sports Med (2007) 0.92
Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa. Diabetes Care (2000) 0.91
Diabetic nephropathy. Br Med Bull (1989) 0.91
Multiple lipoprotein abnormalities in type I diabetic patients with renal disease. Diabetes (1996) 0.91
Quality of life and psychological well-being in GH-treated, adult PWS patients: a longitudinal study. J Intellect Disabil Res (2007) 0.91
Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects. Int J Obes (Lond) (2007) 0.90
Maximal lipid oxidation during exercise: a target for individualizing endurance training in obesity and diabetes? J Endocrinol Invest (2012) 0.89
Transcriptional features of multiple myeloma patients with chromosome 1q gain. Leukemia (2007) 0.89
[Definition of obesity in childhood: criteria and limits]. Minerva Pediatr (2003) 0.89
Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients. Diabetes Obes Metab (2007) 0.88
Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. Am J Med (1983) 0.87
The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes. Nephron (2002) 0.87
Deconvolution of infrequently sampled data for the estimation of growth hormone secretion. IEEE Trans Biomed Eng (1995) 0.87
Neovascularization at the vascular pole region in diabetic glomerulopathy. Nephrol Dial Transplant (1999) 0.87
Growth, growth hormone and cognitive functions. Horm Res (1996) 0.86
The relationship between body composition and muscle power output in men and women with obesity. J Endocrinol Invest (2004) 0.86
Plasma renin activity in insulin-dependent diabetics with raised glomerular filtration rate. Clin Endocrinol (Oxf) (1984) 0.86
Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy. Diabetologia (2008) 0.86
Spontaneous growth hormone and somatomedin-C/insulin-like growth factor-I secretion in obese subjects during puberty. J Endocrinol Invest (1988) 0.85
Prognostic value of estrogen receptor and Ki-67 index after neoadjuvant chemotherapy in locally advanced breast cancer expressing high levels of proliferation at diagnosis. Oncology (2011) 0.85
Early functional and morphological changes in diabetic nephropathy. Clin Nephrol (1979) 0.85
Biosynthetic human insulin: progress and prospects. Diabetes Care (1981) 0.85
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab. Bone Marrow Transplant (2003) 0.85
Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. Nephron (1984) 0.84
[Subclavian and innominate steal syndrome (our experience with 29 patients)]. Chir Ital (1987) 0.84
Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia (1993) 0.84
Plasma insulin and C-peptide after subcutaneous and intravenous administration of human insulin (recombinant DNA) and purified porcine insulin in healthy men. Diabetes Care (1987) 0.84
Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. Nutr Metab Cardiovasc Dis (2010) 0.84
P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia (2003) 0.84
Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant (1997) 0.84
Phenotypic and genotypic switch in Philadelphia-positive, BCR-positive blast crisis of chronic myeloid leukemia. Eur J Haematol (1992) 0.83
Proteinuria and activated T-lymphocytes in diabetic nephropathy. Diabetes (1988) 0.83
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL. Br J Cancer (2002) 0.83
In vitro effect of dopamine on growth hormone (GH) release from human GH-secreting pituitary adenomas. J Clin Endocrinol Metab (1982) 0.83
Detection of potentially reversible diabetic albuminuria. A three-drop agglutination test for urinary albumin at low concentration. Diabetes (1982) 0.83
[Further contribution concerning the action of aceclydine on ocular hypertension]. Ann Ottalmol Clin Ocul (1967) 0.83